Autologous Stem Cell and Non-Stem Cell Based Therapies Market – Global Industry Insights, and Opportunity Analysis – 2025

1
(No Transcript)
2

• REPORT DESCRIPTION

Autologous Stem Cell and Non-Stem Cell Based
Therapies Market Overview Autologous stem-cell
transplantation (also known as autogeneic,
autogenic, or autogenous stem-cell
transplantation or auto-SCT) is the autologous
transplantation of stem cellswhich is,
transplantation in which the undifferentiated
cells or stem cells (cells from which other types
of cells develop) are taken from a person,
accumulated, and given back to the same person
later. Even though it is most often executed by
means of hematopoietic stem cells (antecedent of
cells that forms blood) in hematopoietic stem
cell transplantation, in some cases cardiac cells
are used productively to fix the damages due to
heart attacks. Stem cell transplantation can be
of two types - Autologous stem-cell
transplantation and allogenic stem cell
transplantation. In the later, the recipient and
the donor of stem cells are dissimilar people. In
a good number of allogeneic transplants, the stem
cells are taken from a donor whose cell type
matches closely with the patients cell type. The
best donor in allogenic stem cell transplantation
is an immediate family member, generally a
brother or sister. If the patient does not have a
match in his/her family, a donor may be found
from the public. This is often called a MUD or
matched unrelated donor transplant. This type of
transplant (MUD) is generally riskier. According
to a report by National Cancer Institute, in
2016, around 1,685,210 new cases of cancer were
diagnosed in the U.S. alone. Moreover, it was
also noted that around 595,690 people died from
the disease in the same year. Autologous stem
cell and non-stem cell based therapies is likely
to become one of the preferred treatment for
cancer. As the prevalence of cancer is rising at
a considerable rate, the market is likely to grow
during the forecast period.
3
REPORT DESCRIPTION
Autologous Stem Cell and Non-Stem Cell Based
Therapies Market - Taxonomy On the basis of
application, the global autologous stem cell and
non-stem cell based therapies market is
classified into Neurodegenerative
diseases Cardiovascular diseases Cancer and
autoimmune diseases Skin transplantation Infectiou
s diseaseA primary driver for this market is the
worldwide increase in occurrence of diabetes and
cancer, across all age groups. Furthermore,
increasing old-age population is another driver,
which is anticipated to create a high growth
scenario for the market. Request report sample
for more professional and technical insights
https//www.coherentmarketinsights.com/insight/req
uest-sample/523
4
REPORT DESCRIPTION

• Autologous Stem Cell and Non-Stem Cell Based
  Therapies Market - Key Players
• Major players involved in the global autologous
  stem cell and non-stem cell based therapies
  market
• NeoStem, Inc.
• Aastrom Biosciences
• Fibrocell Science, Inc.
• Genzyme Corporation
• BrainStorm Cell Therapeutics
• Regeneus Ltd.
• Dendreon Corporation.
• Click here to know more about this report
  https//www.coherentmarketinsights.com/ongoing-ins
  ight/autologous-stem-cell-and-non-stem-cell-based-
  therapies-market-523

5
(No Transcript)
6
(No Transcript)
7
(No Transcript)
8
THANK YOU
To know more about us, visit our website
www.coherentmarketinsights.com For sales
queries or new topics email us on
sales_at_coherentmarketinsights.com For other
queries contact Mr. Shah (Manager - Business Deve
lopment) Coherent Market Insights sales_at_coherentm
arketinsights.com 1-206-701-6702